Switch to Colesevelam as Second-Line Therapy
If cholestyramine causes diarrhea at 4 g daily, switch to colesevelam (625 mg tablets, 3 tablets twice daily), which has significantly better tolerability with side effect rates similar to placebo rather than the high gastrointestinal side effects seen with cholestyramine 1.
Why Cholestyramine May Be Causing Diarrhea
The paradox here is that cholestyramine is being used to treat diarrhea (from bile acid malabsorption), yet it's causing diarrhea as a side effect. This occurs because:
- Cholestyramine has high rates of gastrointestinal side effects including diarrhea, bloating, and nausea 1
- The 4 g daily dose is actually the recommended starting dose per FDA labeling 2
- You may be dealing with intolerance rather than therapeutic failure
Primary Recommendation: Switch to Colesevelam
Colesevelam is the preferred second-line bile acid sequestrant (BAST) when cholestyramine is not tolerated 1:
- Efficacy: 57-73% response rate, comparable to cholestyramine's 74% 1
- Tolerability: Side effects occur at rates similar to placebo (40% vs 36.4% placebo), dramatically better than cholestyramine 1
- Dosing: 625 mg tablets, 3 tablets twice daily (total 3.75 g/day) - no titration needed 1
- Convenience: Tablet form versus powder/granules, significantly easier to take 1
- Binding affinity: 4-6 times stronger bile acid binding than cholestyramine 1
The 2020 Canadian Association of Gastroenterology guidelines specifically state that colesevelam has a "favorable benefit:risk profile and greater ease of administration" compared to cholestyramine 1.
Alternative Option: Colestipol
If colesevelam is unavailable or cost-prohibitive, colestipol can be used as second-line therapy 1:
- Limited data but has been reported as effective second-line option 1
- Start at 1 g twice daily, increase by 1 g/day every other day 1
- Less commonly used than colesevelam in clinical practice
Important Caveat: Dose Reduction Strategy
Before switching agents entirely, consider whether you've tried dose reduction of cholestyramine:
- The FDA label recommends starting at 4 g daily (one packet) 2
- You could try reducing to 2 g daily (half packet) if not already attempted
- Gradual titration is recommended to minimize side effects 1
- However, given that 4 g is already the minimum starting dose, switching to colesevelam is more practical
What NOT to Do
- Do not use antiperistaltic agents to counteract the diarrhea while continuing cholestyramine - this doesn't address the underlying intolerance
- Do not continue escalating cholestyramine dose hoping tolerance will improve - side effects typically persist or worsen 1
- Do not use cholestyramine in patients with extensive ileal resection (>100 cm) as it can worsen steatorrhea 1
Clinical Context
In real-world practice, 32% of patients initially started on cholestyramine eventually switch to colesevelam due to tolerability issues 1. This is common and expected. The switch to colesevelam maintains therapeutic efficacy while dramatically improving quality of life through better tolerability.